WOLFGANG WINKELMAYER to Fibrinolytic Agents
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Fibrinolytic Agents.
Connection Strength
1.391
-
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney Int. 2024 07; 106(1):145-153.
Score: 0.803
-
Tackling the Achilles' heel of hemodialysis. N Engl J Med. 2011 Jan 27; 364(4):372-4.
Score: 0.323
-
Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age. Am J Cardiol. 2008 Jun 01; 101(11):1531-6.
Score: 0.265